ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 28 of 33
Up
JMBS 2021, 6(4): 199–207
https://doi.org/10.26693/jmbs06.04.199
Biology

Antibiotic Resistance. Scale and Relevance of Studies of the Antibiotic-Resistant Isolates Circulation among Children

Fohel I. I., Kryvtsova M. V., Bugir Y. Y.
Abstract

Over the last decade, the phenomenon of antibiotic resistance of microorganisms has become a global problem for modern medicine around the world. Bacteria quickly acquire genes of resistance to the action of the antibiotics. Bacterial infections that used to be easy to treat, now, in some cases, can even be life-threatening. Resistant microorganisms pose a danger not only among the adult population but also among the pediatric population. According to the World Health Organization, up to 200,000 newborns die each year from infections caused by antibiotic-resistant microorganisms. Premature babies are at particular risk because their immune systems are still underdeveloped. The use of antibiotics in children should be reasonably approached, as recent studies have shown an increase of the spread of bacteria with resistance genes. Infections caused by resistant microorganisms are more difficult to treat and require special methods and approaches, especially for children, where the choice of antibiotics is already limited. The purpose of the study is to analyze the literature for the current state of the problem of antibiotic resistance, prospects for future development, relevance in pediatric practice. Materials and methods. The research materials are publications of national and foreign authors. Analytical methods were used as main research methods. This article considers the problem of antibiotic resistance, general mechanisms of its formation, research data on the prevalence of circulation of resistant strains in the pediatric population and their role in the initiation of resistant bacterial infections. Conclusion. It is concluded that bacteria insensitive to antibiotics are quite common among the pediatric population and in some cases are life-threatening. This phenomenon requires constant monitoring in order to detect and correctly treat persistent bacterial infections. There are many strains resistant to first- and second-generation antibiotics circulating in children. In some cases, the treatment of certain conditions in pediatrics may lead to the use of reserve antibiotics. Systemic coordinated work around the world and an individual approach in determining the sensitivity of microorganisms to antibiotics in each case can prevent the rapid acquisition of resistance genes by bacteria. It is also necessary to spread information about the threat of antibiotic resistance in order to raise public awareness and counteract the empirical use of antibiotics at home without a prescription. There is also an urgent need to invent new chemical compounds with bactericidal properties as soon as possible

Keywords: antibiotic resistance, resistant strains, pediatrics, antibiotics

Full text: PDF (Ukr) 266K

References
  1. World Health Organization. WHO global strategy for containment of antimicrobial resistance. World Health Organization, 2001. No. WHO/CDS/CSR/DRS/2001.2.
  2. Centers for Disease Control and Prevention. Transatlantic Taskforce on Antimicrobial Resistance (TATFAR). Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/drugresistance/tatfar/about.html
  3. Microbiology Society. The history of antibiotics. Available from: https://microbiologysociety.org/members-outreach-resources/outreach-resources/antibiotics-unearthed/antibiotics-and-antibiotic-resistance/the-history-of-antibiotics.html
  4. Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014; 32: 40-51. https://www.ncbi.nlm.nih.gov/pubmed/24406927. https://doi.org/10.1038/nbt.2786
  5. Fanelli U, Chiné V, Pappalardo M, Gismondi P, Esposito S. Improving the Quality of Hospital Antibiotic Use: Impact on Multidrug-Resistant Bacterial Infections in Children. Front Pharmacol. 2020; 11: 745. https://www.ncbi.nlm.nih.gov/pubmed/32499712. Https://www.ncbi.nlm.nih.gov/pmc/articles/7243475. https://doi.org/10.3389/fphar.2020.00745
  6. Medernach RL, Logan LK. The Growing Threat of Antibiotic Resistance in Children. Infect Dis Clin North Am. 2018; 32(1): 1-17. https://www.ncbi.nlm.nih.gov/pubmed/29406971. Https://www.ncbi.nlm.nih.gov/pmc/articles/5927609. https://doi.org/10.1016/j.idc.2017.11.001
  7. Romanyuk L, Kravets N, Klymniuk S, Kopcha V, Dronova O. Antybiotykorezystentnist umovno-patohennykh mikroorhanizmiv: aktualnist, umovy vynyknennya, shlyakhy podolannya [Antibiotic-Resistance of Opportunistic Microorganisms: Topicality, Conditions of Emergency, Ways of Overcome]. Infektsiyni khvoroby. 2020; (4), 63–71. [Ukrainian]. https://doi.org/10.11603/1681-2727.2019.4.10965
  8. Acquired Resistance. University of Minnesota. Available from: https://amrls.umn.edu/microbiology
  9. Minukhin VV, Zvyahintseva TV. Antybiotykorezystentnist. Suchasnyi pohlyad na problemu ta shlyakhy podolannya [Antibiotic resistance. Modern view of the problem and ways of overcoming]. Zbirnyk tez mizhkafedralnoi naukovo-praktychnoi konferentsiyi. 2014. s.16. [Ukrainian]
  10. Brown SD, Rybak MJ. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. J Antimicrob Chemother. 2004 Aug; 54(Suppl 1): i7-15. https://www.ncbi.nlm.nih.gov/pubmed/15265831. https://doi.org/10.1093/jac/dkh313
  11. Farrel DJ, Jenkins SG. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patiens with respiratory tract infections. J Antimicrob Chemother. 2004; 54(Suppl 1): i17-22. https://www.ncbi.nlm.nih.gov/pubmed/15265832. https://doi.org/10.1093/jac/dkh312
  12. Dekhnich AV. Vyyavlenie rezistentnosti k metitsillinu i drugim β-laktamnym antibiotikam metodom skrininga [Revealing resistance to meticillin and other β-lactam antibiotics by screening]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 1999; 1(1): 89-91. [Russian]
  13. Dykyi OH. Suchasni aspekty zastosuvannya antybakterialnykh preparativ: chastyna 1. Rezystentnist do antybakterialnykh preparativ. [Modern aspects of the use of antibacterial drugs: Part 1. Resistance to antibacterial drugs]. Oblasna asotsiatsiya khirurhiv Zhytomyrshchyny. 2013. [Ukrainian]. Available from: http://www.asz.org.ua/index.php/study/274-suchasni-aspekti-zastosuvannja-antibakterialnih-preparativ-chastina-1-rezistentnist-do-antibakterialnih-preparativ.html
  14. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015 Apr; 40(4): 277-83. https://www.ncbi.nlm.nih.gov/pubmed/25859123. https://www.ncbi.nlm.nih.gov/pmc/articles/4378521
  15. CDC. Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta GA: US Department of Health and Human Services, CDC; 2019. 40 p.
  16. World Health Organization. Antimicrobial resistance. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  17. Murray AK. The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance. Front Microbiol. 2020 May 13; 11: 1020. https://www.ncbi.nlm.nih.gov/pubmed/32574253. Https://www.ncbi.nlm.nih.gov/pmc/articles/7237633. https://doi.org/10.3389/fmicb.2020.01020
  18. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar; 55(3): 105924. https://www.ncbi.nlm.nih.gov/pubmed/32081636. Https://www.ncbi.nlm.nih.gov/pmc/articles/7127800. https://doi.org/10.1016/j.ijantimicag.2020.105924
  19. Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19; 368: m606. https://www.ncbi.nlm.nih.gov/pubmed/32075786. Https://www.ncbi.nlm.nih.gov/pmc/articles/7224340. https://doi.org/10.1136/bmj.m606
  20. O'Neill J. Tackling Drug-Resistant Infections Globally: final report and recommendations. 2016. 81 p.
  21. Strachunskiy LS, Belousov YuB, Kozlov SN. Farmokologiya. Prakticheskoe rukovodstvo po antiinfektsionnoy terapii [Pharmocology. Practical guidance on anti-infectious therapy]. Smolensk; NIIAKh SGMA: 2007. 420 s. [Russian]
  22. Chekman IS, Ed. Farmakolohiya [Pharmocology]. K: Vyshcha shkola; 2001. 598 s . [Ukrainian]
  23. Andrukh VS, Andrukh VN. Pro ratsionalne vykorystannya antybiotykiv u suchasnomu sviti: fokus na pediatriyu [About the rational use of antibiotics in the modern world: focus on pediatrics]. Sovr Pedyatr. 2017; 3: 10-14. [Ukrainian]
  24. Romandini A, Pani A, Schenardi PA, Pattarino GAC, De Giacomo C, Scaglione F. Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future. Antibiotics (Basel). 2021 Apr 6; 10(4): 393. https://www.ncbi.nlm.nih.gov/pubmed/33917430. Https://www.ncbi.nlm.nih.gov/pmc/articles/8067449. https://doi.org/10.3390/antibiotics10040393
  25. Costello A, Peterson SS. Birth in a time of antibiotic-resistant bacteria. 2016. Available from: https://www.who.int/mediacentre/commentaries/antibiotic-resistant-bacteria/en/
  26. Millar MR, Walsh TR, Linton CJ, Zhang S, Leeming JP, Bennett PM; ALSPAC Study Team. Avon. Carriage of antibiotic-resistant bacteria by healthy children. J Antimicrob Chemother. 2001 May; 47(5): 605-10. https://www.ncbi.nlm.nih.gov/pubmed/11328771. https://doi.org/10.1093/jac/47.5.605
  27. Meropol SB, Haupt AA, Debanne SM. Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015. J Pediatric Infect Dis Soc. 2018 Feb 19; 7(1): 36-45. https://www.ncbi.nlm.nih.gov/pubmed/28339695. Https://www.ncbi.nlm.nih.gov/pmc/articles/5907863. https://doi.org/10.1093/jpids/piw093
  28. Ivády B, Kenesei É, Tóth-Heyn P, Kertész G, Tárkányi K, Kassa C, et al. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children. Infection. 2016 Jun; 44(3): 309-21. https://www.ncbi.nlm.nih.gov/pubmed/26546372. https://doi.org/10.1007/s15010-015-0857-8
  29. Adams DJ, Eberly MD, Goudie A, Nylund CM. Rising Vancomycin-Resistant Enterococcus Infections in Hospitalized Children in the United States. Hosp Pediatr. 2016 Jul; 6(7): 404-11. https://www.ncbi.nlm.nih.gov/pubmed/27250774. https://doi.org/10.1542/hpeds.2015-0196
  30. Medernach RL, Logan LK. The Growing Threat of Antibiotic Resistance in Children. Infect Dis Clin North Am. 2018 Mar; 32(1): 1-17. https://www.ncbi.nlm.nih.gov/pubmed/29406971. Https://www.ncbi.nlm.nih.gov/pmc/articles/5927609. https://doi.org/10.1016/j.idc.2017.11.001
  31. Logan LK, Renschler JP, Gandra S, Weinstein RA, Laxminarayan R; Centers for Disease Control; Prevention Epicenters Program. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. Emerg Infect Dis. 2015 Nov; 21(11): 2014-21. https://www.ncbi.nlm.nih.gov/pubmed/26486124. Https://www.ncbi.nlm.nih.gov/pmc/articles/4622248. https://doi.org/10.3201/eid2111.150548
  32. Bryce A, Costelloe C, Wootton M, Butler CC, Hay AD. Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study. J Antimicrob Chemother. 2018 May 1; 73(5): 1359-1367. https://www.ncbi.nlm.nih.gov/pubmed/29385442. Https://www.ncbi.nlm.nih.gov/pmc/articles/5909660. https://doi.org/10.1093/jac/dkx525
  33. Logan LK, Gandra S, Mandal S, Klein EY, Levinson J, Weinstein RA, et al; Prevention Epicenters Program, US Centers for Disease Control and Prevention. Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012. J Pediatric Infect Dis Soc. 2017 Nov 24; 6(4): 352-359. https://www.ncbi.nlm.nih.gov/pubmed/27856730. Https://www.ncbi.nlm.nih.gov/pmc/articles/5907855. https://doi.org/10.1093/jpids/piw064
  34. Li X, Stokholm J, Brejnrod A, Vestergaard GA, Russel J, Trivedi U, et al. The infant gut resistome associates with E. coli, environmental exposures, gut microbiome maturity, and asthma-associated bacterial composition Cell Host Microbe. 2021 Jun 9; 29(6) :975-987.e4. https://www.ncbi.nlm.nih.gov/pubmed/33887206. https://doi.org/10.1016/j.chom.2021.03.017
  35. Massachusetts General Hospital. Pandemic of antibiotic resistance is killing children in Bangladesh, researchers find. ScienceDaily. 2021. Available from: https://www.sciencedaily.com/releases/2021/07/210715090644.htm
  36. Chisti MJ, Harris JB, Carroll RW, Shahunja KM, Shahid ASMSB, Moschovis PP, et al. Antibiotic-Resistant Bacteremia in Young Children Hospitalized With Pneumonia in Bangladesh Is Associated With a High Mortality Rate. Open Forum Infect Dis. 2021 Jul 15; 8(7): ofab260. https://www.ncbi.nlm.nih.gov/pubmed/34277885. Https://www.ncbi.nlm.nih.gov/pmc/articles/8280371. 10.1093/ofid/ofab260.
  37. Kryvtsova MV, Kostenko YeYa. Prospects of the use plant-based and antiseptic preparations for correction of oral cavity microbiota in view of individual peculiarities of associations of opportunistic pathogens. Bulletin of problems biology and medicine. 2019; 2(154): 382-385. https://doi.org/10.29254/2077-4214-2019-4-2-154-382-385
  38. Kryvtsova MV, Kostenko YeYa. Dominant microbial associations of the oral cavity in the conditions of generalized periodontitis and features of there sensitivity to antibacterial drugs. Studia Biologica. 2020: 14(1): 51–62. https://doi.org/10.30970/sbi.1401.613
  39. Kryvtsova MV, Király J, Koščová J, Kostenko YeYa, Bubnov RV, Spivak MYa. Determination of biofilm formation and associated gene detection in Staphylococcus genus isolated from the oral cavity under inflammatory periodontal disease. Studia Biologica. 2020 14(3): 49–64. https://doi.org/10.30970/sbi.1403.627